Edward Burford - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Edward Burford

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Plos One|October 23, 2013

Experimental placebo analgesia changes resting-state alpha oscillationsNathan T M Huneke, Christopher A Brown, Edward Burford, et al.

Open Heart|April 17, 2025

Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstructionEdward Burford, Yande Kasolo, Jane Draper, et al.

Circulation. Genomic and Precision Medicine|November 10, 2025

Mavacamten Monotherapy in Real-World Patients with Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCMOzlem Bilen, Arnon Shmuel Adler, Rachel Bastiaenen, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Plos One|October 23, 2013

Experimental placebo analgesia changes resting-state alpha oscillationsNathan T M Huneke, Christopher A Brown, Edward Burford, et al.

Open Heart|April 17, 2025

Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstructionEdward Burford, Yande Kasolo, Jane Draper, et al.

Circulation. Genomic and Precision Medicine|November 10, 2025

Mavacamten Monotherapy in Real-World Patients with Obstructive Hypertrophic Cardiomyopathy: Evidence From COLLIGO-HCMOzlem Bilen, Arnon Shmuel Adler, Rachel Bastiaenen, et al.

Pageof 1